Emergent BioSolutions



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


Ebitda 更改 日
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 121.55M 4.99M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 59.6M 5.52M 2025-09
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Coherus Biosciences USD -44.34M 9.82M 2025-03
Exact Sciences USD 135.42M 2.8M 2025-09
Exelixis USD 248.93M 28.02M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Lonza CHF 1.01B 54M 2025-12
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Myriad Genetics USD 10.3M 4.2M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Pacira USD 49.36M 4.96M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
United Therapeutics USD 436.8M 34.2M 2025-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Xoma USD 2.52M 7.98M 2024-06


Emergent BioSolutions - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.